Do you have an open mind with regards to intimate relationships? If so, you might want to read on. If not, you can still read and who knows you may gain insight.
There is one factor that is rarely talked about by couples and greatly affects intimate relationships--prevalence of premature ejaculation. It is not much talked about due to the stigma it brings to men. Some may never realize that they are already affected and their relationships are already falling apart.
PE from the word itself is defined as cumming before one can reach the plateau phase. Prior to doctor's intensive research, it was believed to be purely psychological. But now, they discovered that it has something to do with serotonin.
Through the efforts of Merarini Philippines in partnership with the Philippine Urological Association, they have launched an advocacy campaign to control PE. It is to continuously disseminate information that this condition can be treated. Merarini held a talk; Happy Wife Happy Life and keynote speakers were Dr. Dennis Serrano and Dr. Margie Holmes.
Dr. Serrano explained very well the condition, its prevalence what are the available treatments (pharmacological and non-pharmacological). While Dr. Margie Holmes, a relationship guru talked about what is important in a certain relationship. She explained the different stages of every relationship a couple has and greatly put an emphasis on the part that sex is three letter word that needs four letter word to convey it’s true meaning: LOVE, GIVE, LUST, and LAST.
Dapoxetine is the first and only drug specifically developed for the treatment of premature ejaculation and is now approved in over 50 countries. Based on robust clinical trials involving over 16,000 men worldwide, dapoxetine is proven to be well tolerated and to significantly improve all measures of premature ejaculation, including control over ejaculation and sexual satisfaction for the couple. Dapoxetine is available by prescription in 30 mg and 60 mg oral tablets.
About the Menarini Group
Menarini is the world’s largest Italian biopharmaceutical company with a heritage of over 128 years and over 16,000 employees in over 100 countries. Here in Asia-Pacific, Menarini’s vision is to be a leading provider of important healthcare brands to improve the lives of people in the region. Menarini Asia-Pacific operates across the entire commercial value chain, from regulatory approval and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in key therapeutic fields, including Dermatology, Primary Care, Allergy/Respiratory, Cardiovascular, Select Specialty Care, Men’s Health and Consumer Health.
For further information, please visit: www.menariniapac.com.
If you think you have this condition and wants to have free online consult, you may visit this site: Control PE.
If you think you have this condition and wants to have free online consult, you may visit this site: Control PE.
